These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 31502397)

  • 1. Evaluation of the intraoperative human papillomavirus test as a marker of early cure at 12 months after electrosurgical excision procedure in women with cervical high-grade squamous intraepithelial lesion: a prospective cohort study.
    Rabasa J; Bradbury M; Sanchez-Iglesias JL; Guerrero D; Forcada C; Alcalde A; Pérez-Benavente A; Cabrera S; Ramon-Cajal S; Hernandez J; Dinares C; García A; Centeno C; Gil-Moreno A
    BJOG; 2020 Jan; 127(1):99-105. PubMed ID: 31502397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative post-conisation human papillomavirus testing for early detection of treatment failure in patients with cervical intraepithelial neoplasia: a pilot study.
    Torné A; Fusté P; Rodríguez-Carunchio L; Alonso I; del Pino M; Nonell R; Cardona M; Rodríguez A; Castillo P; Pahisa J; Balasch J; Ramírez J; Ordi J
    BJOG; 2013 Mar; 120(4):392-9. PubMed ID: 23189989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.
    Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Garcia S; Campo E; Pahisa J; Ordi J
    Am J Obstet Gynecol; 2007 Oct; 197(4):359.e1-6. PubMed ID: 17714678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women.
    Kang WD; Kim SM
    Menopause; 2016 Jan; 23(1):81-6. PubMed ID: 26057824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with human papillomavirus persistence after loop electrosurgical excision procedure in patients with cervical squamous intraepithelial lesion.
    Li F; Chen A; Shan Y; Yao Y; Lu P; Li N; Ding Z
    J Obstet Gynaecol Res; 2024 Apr; 50(4):639-646. PubMed ID: 38185922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
    van de Laar RLO; Hofhuis W; Duijnhoven RG; Polinder S; Melchers WJG; van Kemenade FJ; Bekkers RLM; Van Beekhuizen HJ
    BMC Cancer; 2020 Jun; 20(1):539. PubMed ID: 32517663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.
    Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A
    Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of HPV DNA Testing in Follow-up after Loop Electrosurgical Excision Procedures in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Kietpeerakool C; Tantipalakorn C; Suprasert P; Siriaunkgul S
    Asian Pac J Cancer Prev; 2015; 16(14):6093-7. PubMed ID: 26320501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
    Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J
    Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia.
    Sarian LO; Derchain SF; Andrade LA; Tambascia J; Morais SS; Syrjänen KJ
    Gynecol Oncol; 2004 Jul; 94(1):181-6. PubMed ID: 15262139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of recurrence and its influencing factors in patients with cervical HSIL within 24 months after LEEP].
    Chen LM; Liu L; Tao X; He Y; Guo LP; Zhang HW; Zhou XR; Sui L
    Zhonghua Fu Chan Ke Za Zhi; 2019 Aug; 54(8):534-540. PubMed ID: 31461810
    [No Abstract]   [Full Text] [Related]  

  • 13. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
    Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F
    Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions.
    Houfflin Debarge V; Collinet P; Vinatier D; Ego A; Dewilde A; Boman F; Leroy JL
    Gynecol Oncol; 2003 Sep; 90(3):587-92. PubMed ID: 13678729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP).
    Duesing N; Schwarz J; Choschzick M; Jaenicke F; Gieseking F; Issa R; Mahner S; Woelber L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure.
    Kang WD; Oh MJ; Kim SM; Nam JH; Park CS; Choi HS
    Am J Obstet Gynecol; 2010 Jul; 203(1):72.e1-6. PubMed ID: 20417477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative Human Papillomavirus Test Predicts 24-Month High-Grade Squamous Intraepithelial Lesion Recurrence Saving Costs: A Prospective Cohort Study.
    Rabasa J; Alcalde A; Bradbury M; Sánchez-Iglesias JL; Guerrero D; Forcada C; Pérez-Benavente A; Cabrera S; Ramón Y Cajal S; Hernández J; García Á; Centeno C; Gil-Moreno A
    J Low Genit Tract Dis; 2020 Oct; 24(4):367-371. PubMed ID: 32569022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the short-term disease recurrence after loop electrosurgical excision procedure (LEEP).
    Papalia N; Rohla A; Tang S; Nation J; Nelson G
    BMC Womens Health; 2020 Feb; 20(1):34. PubMed ID: 32102650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases].
    Liu L; Chen LM; Tao X; Dai F; Guo LP; Zhang HW; Zhou XR; Sui L
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):751-756. PubMed ID: 29179270
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia.
    Du R; Meng W; Chen ZF; Zhang Y; Chen SY; Ding Y
    Eur J Gynaecol Oncol; 2013; 34(6):548-51. PubMed ID: 24601049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.